Another lungworm article - what's different about this one?

Lungworm (Angiostrongylus vasorum) infection in dogs is a hot topic at the moment. The disease is potentially fatal and difficult to diagnose, and so it naturally arouses fear (which may have been enhanced by a very emotive publicity campaign). There is also quite a bit of confusion as a result of incomplete information (e.g. about prevalence, mortality rate) and different opinions on how often dogs should be wormed. But most practitioners don't have time to read, and keep up to date with, all the latest research on lungworms. So the need for a concise and impartial presentation of the facts made A. vasorum infection an obvious topic for a Veterinary Prescriber module.

We commissioned a specialist (Dr. Hany Elsheikha, Associate Professor and European diplomate in veterinary parasitology, University of Nottingham) to summarise current knowledge about the management of canine lungworm, ensuring that questions important to veterinary practitioners were addressed. Our editorial process involves integrating referees’ comments, critical appraisal of the evidence and rigorous checks. The result is a succinct, reliable and impartial presentation of the facts. Just as important, the module clearly highlights what is still not known about lungworm.

The module has the following headings: • About Angiostrogylus vasorum and other lungworms in dogs • How do dogs become infected? • Lifecycle of A. vasorum (slideshow) • Pre-patent period • Clinical signs of infection • How likely is a dog to die from infection? • Diagnosis • Spread of A. vasorum in the UK • Treatment of angiostrongylosis • Clinical trials of angiostrongylosis treatment • Preventive therapy • Assessing risk • Product choice • Published trials of preventive therapy • Conclusion

It gives veterinary surgeons the information they need to be able to advise clients confidently about the risks of A. vasorum and make informed decisions about the management of the disease in individual dogs.

Veterinary Prescriber is completely independent and funded by subscription.